3,589 Shares in DENTSPLY SIRONA Inc. (XRAY) Purchased by Comerica Securities Inc.

Comerica Securities Inc. acquired a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 3,589 shares of the medical instruments supplier’s stock, valued at approximately $233,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of XRAY. Russell Investments Group Ltd. increased its stake in shares of DENTSPLY SIRONA by 20.6% during the 1st quarter. Russell Investments Group Ltd. now owns 158,817 shares of the medical instruments supplier’s stock valued at $9,920,000 after acquiring an additional 27,145 shares during the last quarter. Canada Pension Plan Investment Board increased its stake in shares of DENTSPLY SIRONA by 109.6% during the 1st quarter. Canada Pension Plan Investment Board now owns 25,993 shares of the medical instruments supplier’s stock valued at $1,623,000 after acquiring an additional 13,593 shares during the last quarter. Comerica Bank increased its stake in shares of DENTSPLY SIRONA by 2.9% during the 1st quarter. Comerica Bank now owns 60,531 shares of the medical instruments supplier’s stock valued at $3,842,000 after acquiring an additional 1,734 shares during the last quarter. UBS Asset Management Americas Inc. increased its stake in shares of DENTSPLY SIRONA by 4.1% during the 1st quarter. UBS Asset Management Americas Inc. now owns 1,024,996 shares of the medical instruments supplier’s stock valued at $64,001,000 after acquiring an additional 40,816 shares during the last quarter. Finally, Toronto Dominion Bank increased its stake in shares of DENTSPLY SIRONA by 56.0% during the 1st quarter. Toronto Dominion Bank now owns 65,854 shares of the medical instruments supplier’s stock valued at $4,113,000 after acquiring an additional 23,630 shares during the last quarter. 93.87% of the stock is owned by institutional investors.

A number of research firms have recently commented on XRAY. BidaskClub downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Wednesday, July 19th. Credit Suisse Group reaffirmed an “outperform” rating and set a $75.00 price objective (up previously from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. Zacks Investment Research upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 target price for the company in a report on Thursday, July 13th. HC Wainwright began coverage on DENTSPLY SIRONA in a report on Tuesday, July 11th. They set a “buy” rating and a $74.00 target price for the company. Finally, Cleveland Research upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $65.73.

Shares of DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 59.34 on Monday. The company’s 50 day moving average price is $57.21 and its 200 day moving average price is $61.78. DENTSPLY SIRONA Inc. has a 52-week low of $52.53 and a 52-week high of $65.68. The firm’s market capitalization is $13.62 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 EPS for the quarter, hitting analysts’ consensus estimates of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The business had revenue of $992.70 million during the quarter, compared to analysts’ expectations of $1 billion. During the same period last year, the company posted $0.76 EPS. The business’s revenue was down 2.9% on a year-over-year basis. Analysts forecast that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be paid a dividend of $0.0875 per share. The ex-dividend date is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.59%. DENTSPLY SIRONA’s dividend payout ratio is presently -10.09%.

TRADEMARK VIOLATION WARNING: This news story was first posted by Transcript Daily and is the property of of Transcript Daily. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at https://transcriptdaily.com/2017/09/18/3589-shares-in-dentsply-sirona-inc-xray-purchased-by-comerica-securities-inc.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply